Lucie Heinzerling

Statistics

Publications

Citations

458

H-Index

Active since

2021

Affiliations

Ludwig-Maximilians-Universität München(Current)

Universitätsklinikum Erlangen

Friedrich-Alexander-Universität Erlangen-Nürnberg

LMU Klinikum

University of Miami

Lucie Heinzerling is an author at Ludwig-Maximilians-Universität München specializing in oncology, checkpoint inhibitor therapy, and immune checkpoint inhibitors.

ORCID

Publications per year

2021–2025

Publications

Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis

Paaladinesh Thavendiranathan, Lili Zhang, Amna Zafar et al. · Journal of the American College of Cardiology · 2021 · 188 citations · Full text

Life Sciences, Cardiology, Immunology +16

Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors

Theresa Ruf, Rafaela Kramer, Andrea Forschner et al. · European Journal of Cancer · 2024 · 47 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Immune checkpoint inhibitor-associated myocarditis: a novel risk score

John R. Power, Charles Dolladille, Benay Özbay et al. · European Heart Journal · 2025 · 40 citations · Full text

Medicine, Cardiology, Immunology +14

Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors

Dirk Tomsitz, Theresa Ruf, Sarah Zierold et al. · Cancers · 2023 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Leonie Müller‐Jensen, Sarah Zierold, Judith M. Versluis et al. · European Journal of Cancer · 2022 · 38 citations · Full text

Medicine, Neurology, Oncology +17

1–5 of 12